In preclinical murine models, the combined loss of Asxl1 and Tet2 from specific hematopoietic cells resulted in an accelerated onset of MDS (Abdel-Wahab et al., 2013). This evidence concerns the gene ASXL1 and myelodysplastic syndrome.